Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

49.51
Delayed Data
As of Apr 21
 -0.95 / -1.88%
Today’s Change
31.38
Today|||52-Week Range
80.11
+32.24%
Year-to-Date

Today’s Trading

Previous close50.46
Today’s open50.57
Day’s range49.19 - 51.22
Volume664,849
Average volume (3 months)984,138
Market cap$4.3B
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-7.98%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book4.62

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-3.65-0.43%
OPKOPKO Health Inc-0.16-2.10%
AKRXAkorn Inc-0.09-0.27%
GLPGGalapagos NV-3.25-3.65%
Data as of 4:00pm ET, 04/21/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs